Task Force Overview
From LipidomicsWiki
(Difference between revisions)
Line 1: | Line 1: | ||
The LipidomicNet consortium consists of six vertical (TFI-VI) and three horizontal integrative (TFVII-TFIX) task forces.<br>Specific enabling technologies and their applications (TF I-IV).<br>Mouse models (TF V).<br>Human clinical trials and ethics issues (TF VI).<br>Translational research (TF VII).<br>LipidomicNet (TF VIII).<br>Dissemination and training (TF IX).<br> | The LipidomicNet consortium consists of six vertical (TFI-VI) and three horizontal integrative (TFVII-TFIX) task forces.<br>Specific enabling technologies and their applications (TF I-IV).<br>Mouse models (TF V).<br>Human clinical trials and ethics issues (TF VI).<br>Translational research (TF VII).<br>LipidomicNet (TF VIII).<br>Dissemination and training (TF IX).<br> | ||
+ | |||
+ | |||
+ | <br> | ||
Line 7: | Line 10: | ||
- | <br> | + | <br> |
+ | <br> | ||
+ | |||
+ | |||
+ | <br> | ||
Line 80: | Line 87: | ||
| Karpe | | Karpe | ||
- | | [[P01 UHREG|P01]], [[P08 UGOT|P08]], [[P09 JUMC|P09]], [[P11 BRC HAS|P11]], [[P12 IEE SAS|P12]], [[P13 BABRAHAM|P13]], [[P14 UH|P14]], [[ | + | | [[P01 UHREG|P01]], [[P08 UGOT|P08]], [[P09 JUMC|P09]], [[P11 BRC HAS|P11]], [[P12 IEE SAS|P12]], [[P13 BABRAHAM|P13]], [[P14 UH|P14]], [[P15A UBO|P15A]], [[P15B UBO|P15B]], [[P22 UOXF.H7|22]], [[P23 MRC|P23]], and [[P24 JKU|P24]] |
|- | |- | ||
! Horizontal Task Forces | ! Horizontal Task Forces |
Revision as of 09:14, 23 May 2011
The LipidomicNet consortium consists of six vertical (TFI-VI) and three horizontal integrative (TFVII-TFIX) task forces.
Specific enabling technologies and their applications (TF I-IV).
Mouse models (TF V).
Human clinical trials and ethics issues (TF VI).
Translational research (TF VII).
LipidomicNet (TF VIII).
Dissemination and training (TF IX).
Overview of LipidomicNet Task Forces
The following table shows an overview of the task forces their Leaders and corresponding LipidomicNet partners.
Vertical Task Forces | Taskforce | chair | co-chair | Partner(s) |
---|---|---|---|---|
Task Force I | Mass-spectrometric and chromatographic methods andpreanalytics for molecular lipid species analyses and stable isotope labelling | Prof. Micheal Wakelam | PhD. Gerhard Liebisch | P01, P02, P04, P06, P07, P11, P13, P14, P15A, P15B, P17, P18, P19, P21, P22, P25 |
Task Force II | Fluorescence-based lipidomic methods on intact cells, labelling lipidomic antibodies and proteins | Dr. Christoph Thiele | Prof. Dr. Aldona Dembinska-Kiec | P01, P04, P09, P11, P13, P14, P15B, P23, P24 |
Task Force III | Affinity binder, ELISA and proteomic mass-spectrometric techniques and reagents | Dr. Stefan Müllner | Dr. Jens Hansen | P01, P07, P16, P20 |
Task Force IV | Gene-, Taqman- and Bead-array reagents and preanalytics (RNA/DNA, Agilent, Affymetrix, Illumina, ABI TLDAs etc) | Prof. Dr. Gerd Schmitz | Dr. Christian Wolfrum | P01, P06, P09 |
Task Force V | Mouse models | Dr. Christian Wolfrum | Van Dijk | P02, P03, P04, P05, P06, and P07 |
Task Force VI | Clinical trials and human ethics | Daniela Gasperikova | Karpe | P01, P08, P09, P11, P12, P13, P14, P15A, P15B, 22, P23, and P24 |
Horizontal Task Forces | | | | |
Task Force VII | Human/Mouse translational research | Prof. Dr. Gerd Schmitz | Dr. Isabell Dugail | P01, P04, P06, P12, P13, P15A |
Task Force VIII | LipidomicNet-Bioinformatics | Dr. Lennart Martens | Prof. Dr. Gerd Schmitz | P01, P06, P10, P16, P17, P18, P21, P22, P25 |
Task Force IX | Dissemination, training and communication | Prof. Dr. Aldona Dembinska-Kiec | Juergen Jonas | All partners |
Together the specialized vertical and the integrative horizontal Task Forces (TFs) will generate maximal integration and efficient dissemination and training.